STLN compared with TOI: revenue, margins and what each company keeps, and the suppliers and customers both name

STLNStarling Oncology, Inc.

Mkt capRevenueRevenue

TOIOncology Institute, Inc.

Mkt capRevenueRevenue

Compare

STLNStarling Oncology, Inc.

TOIOncology Institute, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

STLNStarling Oncology, Inc.

6.71▼−3.36%· post 5.75

Mkt cap$707.3MRevenue$161MQ2 FY26Revenue$503MFY25

TOIOncology Institute, Inc.

6.71▼−3.36%· post 5.75

ClosedNov 5 '26

Mkt cap$682.8MRevenue$161MQ2 FY26Revenue$503MFY25

Compare

ClosedNov 5 '26

STLNStarling Oncology, Inc.

TOIOncology Institute, Inc.

6.71▼−3.36%post 5.75

Price

6.71▼−3.36%post 5.75

$707.3M

Mkt cap

$682.8M

Q2 FY26$161M

Revenue

$161MQ2 FY26

FY25$503M

Revenue

$503MFY25

STLN6.71▼−3.36%vsTOI6.71▼−3.36%ClosedNov 5 '26

Earnings history

last 4 reports each · paired by recencyMethod ›

STLN

No earnings history for STLN.

TOI

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±13.5%▲+28.46%×2.11

May 8 '26±18.3%▼−1.72%×0.09

Q1 FY26±75.8%▲+8.40%×0.11

Jan 12 '26±9.3%▼−7.89%×0.85

= impliedSTLN realized, solidTOI realized, hatchedOne scale, both sides: full bar = 76%× = |realized| ÷ impliedSource: market data